![](/img/cover-not-exists.png)
Phase III Trial Comparing Granulocyte Colony-Stimulating Factor to Leridistim in the Prevention of Neutropenic Complications in Breast Cancer Patients Treated with Docetaxel/Doxorubicin/Cyclophosphamide: Results of the BCIRG 004 Trial
Jean-Marc Nabholtz, Jacques Cantin, Jose Chang, Raymond Guevin, Ravi Patel, Katherine Tkaczuk, Pavel Vodvarka, Mary-Ann Lindsay, David Reese, Alessandro Riva, John MackeyVolume:
3
Year:
2002
Language:
english
DOI:
10.3816/cbc.2002.n.030
File:
PDF, 161 KB
english, 2002